Cargando…

Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression

BACKGROUND: Despite the importance of androgen receptor (AR) signalling to prostate cancer development, little is known about how this signalling pathway changes with increasing grade and stage of the disease. OBJECTIVE: To explore changes in the normal AR transcriptome in localised prostate cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stuchbery, Ryan, Macintyre, Geoff, Cmero, Marek, Harewood, Laurence M., Peters, Justin S., Costello, Anthony J., Hovens, Christopher M., Corcoran, Niall M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058764/ https://www.ncbi.nlm.nih.gov/pubmed/27120785 http://dx.doi.org/10.18632/oncotarget.8915

Ejemplares similares

Comparing nodal versus bony metastatic spread using tumour phylogenies
por: Mangiola, Stefano, et al.
Publicado: (2016)

A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance
por: Sapre, Nikhil, et al.
Publicado: (2016)

Inferring structural variant cancer cell fraction
por: Cmero, Marek, et al.
Publicado: (2020)

Author Correction: Inferring structural variant cancer cell fraction
por: Cmero, Marek, et al.
Publicado: (2022)

Loss of SNAI2 in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy
por: Cmero, Marek, et al.
Publicado: (2021)

Biomarkers of Response to Neoadjuvant Androgen Deprivation in Localised Prostate Cancer
por: Pechlivanis, Maree, et al.
Publicado: (2021)

Curated MicroRNAs in Urine and Blood Fail to Validate as Predictive Biomarkers for High-Risk Prostate Cancer
por: Sapre, Nikhil, et al.
Publicado: (2014)

Androgen deprivation therapy promotes an obesity-like microenvironment in periprostatic fat
por: Mangiola, Stefano, et al.
Publicado: (2019)

Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array
por: Naeem, Haroon, et al.
Publicado: (2014)

Error rates in a clinical data repository: lessons from the transition to electronic data transfer—a descriptive study
por: Hong, Matthew K H, et al.
Publicado: (2013)

Preparation of fluorescent in situ hybridisation probes without the need for optimisation of fragmentation
por: McCoy, Patrick J., et al.
Publicado: (2018)

Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progression
por: Lau, Edmund, et al.
Publicado: (2020)

Glutathione localisation in benign and malignant human breast lesions.
por: Murray, G. I., et al.
Publicado: (1987)

Transcriptome sequencing and multi-plex imaging of prostate cancer microenvironment reveals a dominant role for monocytic cells in progression
por: Mangiola, Stefano, et al.
Publicado: (2021)

Molecular Mechanisms Driving the Formation of Brain Metastases
por: Campbell, Bethany K., et al.
Publicado: (2022)

Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer
por: Corcoran, N M, et al.
Publicado: (2010)

Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer
por: Hong, Matthew K.H., et al.
Publicado: (2015)

Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002)

Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped reads
por: Schröder, Jan, et al.
Publicado: (2014)

Mitochondrial genome variation and prostate cancer: a review of the mutational landscape and application to clinical management
por: Kalsbeek, Anton M.F., et al.
Publicado: (2017)

Immunohistochemical localisation of pS2 protein in ductal carcinoma in situ and benign lesions of the breast.
por: Luqmani, Y. A., et al.
Publicado: (1993)

Immunocytochemical localisation of follicle stimulating hormone (FSH) in normal, benign and malignant human prostates.
por: Hurkadli, K. S., et al.
Publicado: (1990)

Health Economic Evidence for Liquid- and Tissue-based Molecular Tests that Inform Decisions on Prostate Biopsies and Treatment of Localised Prostate Cancer: A Systematic Review
por: Degeling, Koen, et al.
Publicado: (2021)

Perish and publish: Dynamics of biomedical publications by deceased authors
por: Jung, Chol-Hee, et al.
Publicado: (2022)

Hallmarks of cancer and hallmarks of aging
por: Blagosklonny, Mikhail V.
Publicado: (2022)

Expression, localisation and potential significance of aquaporins in benign and malignant human prostate tissue
por: Bründl, Johannes, et al.
Publicado: (2018)

Defining Prostatic Vascular Pedicle Recurrence and the Anatomy of Local Recurrence of Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography
por: Dundee, Philip, et al.
Publicado: (2022)

Using equivalence class counts for fast and accurate testing of differential transcript usage
por: Cmero, Marek, et al.
Publicado: (2019)

Transcriptomic Hallmarks of Ischemia-Reperfusion Injury
por: Movahed, Mandana, et al.
Publicado: (2021)

Localisation and Function of the Endocannabinoid System in the Human Ovary
por: El-Talatini, Mona R., et al.
Publicado: (2009)

Reduction of coherent artefacts in super‐resolution fluorescence localisation microscopy
por: GEORGIADES, PANTELIS, et al.
Publicado: (2016)

Heparanase and the hallmarks of cancer
por: Jayatilleke, Krishnath M., et al.
Publicado: (2020)

An Update to Hallmarks of Cancer
por: Ravi, Swapna, et al.
Publicado: (2022)

FDG PET/CT detects benign neurofibromas presenting as nodal masses: Imaging hallmarks of a diagnostic “red herring”
por: Puranik, Ameya D., et al.
Publicado: (2015)

Expression and protein localisation of IGF2 in the marsupial placenta
por: Ager, Eleanor I, et al.
Publicado: (2008)

MINTIE: identifying novel structural and splice variants in transcriptomes using RNA-seq data
por: Cmero, Marek, et al.
Publicado: (2021)

Antioxidant mitoquinone suppresses benign prostatic hyperplasia by regulating the AR–NLRP3 pathway
por: Jin, Bo-Ram, et al.
Publicado: (2023)

Inhibiting CBP Decreases AR Expression and Inhibits Proliferation in Benign Prostate Epithelial Cells
por: Tang, Xingxing, et al.
Publicado: (2023)

The “hallmark” cells
por: Pandiar, Deepak, et al.
Publicado: (2019)

Hallmarks of ribosomopathies
por: Kampen, Kim R, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4vsjs4fn5gdeis3o4uivajliac